Last update:

Medications news

Medications

Prescription painkiller misuse and addiction are widespread in chronic pain patients

A new scientific review of 148 studies enrolling over 4.3 million adult chronic pain patients treated with prescription opioid painkillers has found that nearly one in ten patients experiences opioid dependence or opioid ...

Medications

Generations of young women have been bombarded with weight loss medications—'skinny jabs' are just the latest

"I couldn't stop being sick. My side and my back were hurting and I just felt like my body was totally shutting down." That's how one woman described the side effects of weight loss injections she'd bought off-label in a ...

Medications

FDA approves drug targeting brain cancer gene mutation

A new drug for treatment of a type of brain cancer, called IDH-mutant low-grade glioma, was approved Aug. 6 by the U.S. Food and Drug Administration (FDA). The promising new drug stems from a 2008 genetic discovery made at ...

Medications

Study finds sex bias in emergency department pain management

A new study reveals a significant sex bias in pain management at emergency departments, showing that female patients are consistently less likely to receive pain medication prescriptions compared to male patients with similar ...

Medications

A new drug could turn back the clock on multiple sclerosis

Multiple sclerosis (MS) degrades the protective insulation around nerve cells, leaving their axons, which carry electrical impulses, exposed like bare wires. This can cause devastating problems with movement, balance and ...

Medications

Psoriasis drug shows promise for treating childhood diabetes

A drug that is currently used for the treatment of psoriasis has been found to be effective in treating the early stages of type-1 diabetes in children and adolescents, finds a new clinical trial led by Cardiff University.

Medications

New drug candidate blocks resistance to cancer therapies

A team of researchers at the University of Michigan Health Rogel Cancer Center has designed a molecule that impairs signaling mediated by two key drivers of cancer therapy resistance. The design and preclinical evaluation ...

Medications

European medicines watchdog rejects new Alzheimer's drug

Europe's medicines watchdog on Friday rejected a marketing request for a new Alzheimer's disease treatment, saying the risks of the medicine's side effects, including potential brain bleeding, outweighed the benefits.